Lactate Dehydrogenase and Body Mass Index are Prognostic Factors in Patients with Recurrent Small Cell Lung Cancer Receiving Amrubicin - Concepedia

Concepedia

Publication | Closed Access

Lactate Dehydrogenase and Body Mass Index are Prognostic Factors in Patients with Recurrent Small Cell Lung Cancer Receiving Amrubicin

21

Citations

10

References

2015

Year

Minehiko Inomata, Ryuji Hayashi, Kotaro Tokui, Chihiro Taka, Seisuke Okazawa, Kenta Kambara, Tomomi Ichikawa, Tom Yamada, Toshiro Miwa, Tatsuhiko Kashii,

Abstract

Our findings suggest that the plasma LDH level and BMI may be useful prognostic factors in patients with SCLC receiving amrubicin monotherapy, including patients with platinum-resistant disease.

References

	Year	Citations

Page 1